Verge HealthTech Fund invests in ThinkMD
Roughly 15 million health workers are missing from the global healthcare system, concentrated in sub-Saharan Africa, South Asia and Latin America. High-income countries have around 3.59 doctors per 1,000 people, against as few as 0.35 in low-income countries.
ThinkMD translates decades of physician reasoning into a mobile, offline-capable, multilingual decision-support tool. It covers more than 200 conditions across newborn, child, antenatal, postnatal and adult care, ships in 22 languages, and is validated at 85% to 95% correlation with physician assessment. Almost all processing happens on the device itself, so the tool works where there is no internet connection. To date the platform has powered more than 50 million clinical encounters across seven countries, in roughly 885 facilities, by around 9,000 frontline workers. Partners report a 50% drop in training costs and a 60% lift in protocol adherence.
Verge passed on ThinkMD twice before investing, changing its view after meeting CEO Chris Marr, a repeat founder who rebuilt the company around a distribution-first strategy and nearly doubled annual contracted revenue within twelve months across Sierra Leone, Nigeria, Rwanda, Kenya, Zambia, Somalia and Papua New Guinea. Professor Barry Finette, who founded the company and developed its underlying clinical logic, remains as Chief Medical and Science Officer.
The longer-term thesis is the data. Every assessment captures structured, geolocated clinical information, which over time builds into a longitudinal, clinically validated diagnostic dataset for the Global South. For governments, that could mean real-time visibility into community health, early warning of disease outbreaks and evidence for allocating resources. Pilots in Somalia and Nigeria are next.
"It is somewhat fitting that a noble solution like this signifies our 40th investment," wrote Joseph Mocanu, Managing Partner at Verge HealthTech Fund, in his article announcing the deal.
As health systems across the region look for ways to extend a workforce that does not exist, tools that put clinical reasoning in the hands of the workers already on the ground are drawing growing investor attention.
For more information, please visit Verge HealthTech Fund's announcement.
Newer
There are no newer news
